Introduction Community-acquired pneumonia (CAP) is a common infection associated with
high morbimortality and a highly deleterious impact on patients' quality of life and …

Community-acquired pneumonia represents the third-highest cause of mortality in
industrialized countries and the first due to infection. Although guidelines for the approach to …

A well‐established mechanism of action for managing pneumonia using Glycyrrhiza is
unknown. Using network pharmacology and molecular docking simulations, we investigated …

Abstract Context Qiangli Wuhu (QLWH) mixture is a concoction approved and registered by
Ningxia Medical Products Administration. It has therapeutic effects on various types of …

Streptococcus pneumoniae is a major pathogen responsible for severe complications in
patients with prior influenza A virus (IAV) infection. We have previously demonstrated that S …

Respiratory virus infections remain a significant challenge to human health and the social
economy. The symptoms range from mild rhinitis and nasal congestion to severe lower …

The appearance of new respiratory virus infections in humans with epidemic or pandemic
potential has underscored the urgent need for effective broad-spectrum antivirals (BSAs) …

Although the omicron variant of SARS-CoV-2 circulated intensely during the 2021–2022
season, many patients with severe acute respiratory disease tested negative for COVID-19 …

Respiratory viruses are increasingly recognized as a cause of community-acquired
pneumonia (CAP). The implementation of new diagnostic technologies has facilitated their …

Methods: A total of 69,086 children with acute respiratory infections hospitalized and treated
in our department from January 2018 to December 2022 were enrolled as our research …